Rock Springs Capital Management LP
104 holdingsFiling period: 2026-06-30Current AUM: $2.04Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 1.11M | $207.0M | $226.4M | 11.08% | -104,255 | 2026-06-30 |
| 2 | TVTX | TRAVERE THERAPEUTICS INC | 2.18M | $123.8M | $136.2M | 6.67% | +701.1K | 2026-06-30 |
| 3 | LLY | ELI LILLY & CO | 98.7K | $118.4M | $112.1M | 5.49% | -- | 2026-06-30 |
| 4 | MDGL | MADRIGAL PHARMACEUTICALS INC | 175.0K | $94.0M | $91.6M | 4.48% | +4.0K | 2026-06-30 |
| 5 | MIRM | MIRUM PHARMACEUTICALS INC | 798.1K | $93.4M | $74.9M | 3.67% | -13,149 | 2026-06-30 |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | 692.6K | $76.9M | $67.0M | 3.28% | +2.9K | 2026-06-30 |
| 7 | KYMR | KYMERA THERAPEUTICS INC | 453.2K | $52.0M | $51.3M | 2.51% | -43,715 | 2026-06-30 |
| 8 | ARGX | ARGENX SE | 52.8K | $48.9M | $51.7M | 2.53% | -45,750 | 2026-06-30 |
| 9 | — | ASCENDIS PHARMA A/S | 168.8K | $45.0M | $45.0M | 2.20% | -- | 2026-06-30 |
| 10 | XENE | XENON PHARMACEUTICALS INC | 683.9K | $41.3M | $38.5M | 1.88% | -79,113 | 2026-06-30 |
| 11 | SRRK | SCHOLAR ROCK HLDG CORP | 715.5K | $39.3M | $35.8M | 1.75% | -24,364 | 2026-06-30 |
| 12 | INSM | INSMED INC | 362.1K | $38.6M | $43.4M | 2.13% | +47.9K | 2026-06-30 |
| 13 | PEN | PENUMBRA INC | 115.8K | $36.5M | $36.9M | 1.80% | -4,750 | 2026-06-30 |
| 14 | GPCR | STRUCTURE THERAPEUTICS INC | 640.3K | $34.4M | $24.9M | 1.22% | +100 | 2026-06-30 |
| 15 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 967.9K | $32.3M | $12.6M | 0.62% | -250,918 | 2026-06-30 |
| 16 | IRTC | IRHYTHM HOLDINGS INC | 269.6K | $32.1M | $30.2M | 1.48% | +7.9K | 2026-06-30 |
| 17 | ISRG | INTUITIVE SURGICAL INC | 76.5K | $30.4M | $28.8M | 1.41% | -5,540 | 2026-06-30 |
| 18 | AGL | AGILON HEALTH INC | 262.6K | $28.1M | $24.2M | 1.18% | +2.6K | 2026-06-30 |
| 19 | UNH | UNITEDHEALTH GROUP INC | 63.8K | $26.5M | $24.0M | 1.17% | +10.8K | 2026-06-30 |
| 20 | CLDX | CELLDEX THERAPEUTICS INC NEW | 699.1K | $26.0M | $26.9M | 1.32% | +48.9K | 2026-06-30 |
| 21 | ERAS | ERASCA INC | 1.40M | $25.7M | $22.8M | 1.12% | +298.7K | 2026-06-30 |
| 22 | NBIX | NEUROCRINE BIOSCIENCES INC | 144.8K | $24.4M | $21.7M | 1.06% | -5,700 | 2026-06-30 |
| 23 | ELVN | ENLIVEN THERAPEUTICS INC | 464.6K | $23.6M | $24.8M | 1.21% | -361,875 | 2026-06-30 |
| 24 | THC | TENET HEALTHCARE CORP | 125.0K | $23.4M | $32.6M | 1.60% | -- | 2026-06-30 |
| 25 | DXCM | DEXCOM INC | 343.0K | $23.1M | $29.7M | 1.45% | -12,600 | 2026-06-30 |
← Scroll →
Page 1 of 5